Great question! MALT lymphoma itself is not commonly associated with hair loss. Hair loss is more frequently linked to certain types of lymphoma, such as cutaneous lymphoma, rather than MALT lymphoma specifically. As for Rituximab, it falls under the category of targeted therapy (an antibody drug). Hair loss from targeted Show Full Answer
Great question! MALT lymphoma itself is not commonly associated with hair loss. Hair loss is more frequently linked to certain types of lymphoma, such as cutaneous lymphoma, rather than MALT lymphoma specifically. As for Rituximab, it falls under the category of targeted therapy (an antibody drug). Hair loss from targeted drugs is considered less common — fewer than 15% of people receiving targeted therapy experience it.
Here's a quick summary of hair loss likelihood by treatment type:
- Chemotherapy — Most common cause of hair loss
- Radiation therapy — Hair loss occurs at the treatment site
- Targeted therapy (like Rituximab) — Less than 15% of people experience hair loss
- Immunotherapy — Fewer than 2% of people experience hair loss
The good news is that if hair loss does occur from Rituximab, it is likely to grow back. As always, it's worth discussing any concerns about hair loss with your oncology team, as they can give guidance specific to your treatment plan.
July 1
Join
Your Privacy Choices
